发明名称 Cyanoisoquinoline compounds and methods of use thereof
摘要 The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure:;
申请公布号 US9174976(B2) 申请公布日期 2015.11.03
申请号 US201414289573 申请日期 2014.05.28
申请人 FIBROGEN, INC. 发明人 Arend Michael;Flippin Lee A.;Wu Min;Turtle Eric D.;Ho Wen-Bin;Deng Shaojiang
分类号 A61K31/47;A61K31/435;A61K31/44;C07D417/12;C07D217/26;C07D405/12;C07D413/12 主分类号 A61K31/47
代理机构 Sheppard Mullin Richter & Hampton LLP 代理人 Sheppard Mullin Richter & Hampton LLP
主权项 1. A method for inhibiting a HIF hydroxylase in a subject, the method comprising administering to the subject a compound of formula I: wherein: R is selected from the group consisting of hydrogen, alkyl, and substituted alkyl; R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen, halo, cyano, hydroxyl, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, amino, substituted amino, —OR7, —SR7, —SOR7, and —SO2R7 wherein R7 is selected from the group consisting of alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl; R5 and R6 are independently selected from the group consisting of hydrogen and C1-3 alkyl; or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof; or an ester or amide of the carboxylic acid moiety on the glycine or alanine-based substituent of the cyanoisoquinoline ring.
地址 San Francisco CA US